PUBLISHER: Grand View Research | PRODUCT CODE: 1678674
PUBLISHER: Grand View Research | PRODUCT CODE: 1678674
The global catheter market size is anticipated to reach USD 85.19 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 6.6% from 2025 to 2030. Rising healthcare expenditure, increasing collaboration and partnerships among the industry key players, increasing number of surgeries due to a rise in the number of chronic ailments such as diabetes, cardiovascular disorders, urological disorders, end-stage renal diseases, and other chronic conditions is expected to increase the adoption rate of catheters, thus driving the market over the forecast period.
Moreover, the increasing cases of bladder cancer boost the demand for catheters driving industry growth. For instance, American Cancer Society projected around 82,290 new cases of bladder cancer in the U.S. in 2023, with approximately 62,420 in men & 19,870 in women, the demand for specialized catheters like the 4-way Foley catheter is anticipated to be high, driven by the importance of effective therapeutic interventions in bladder cancer management. As the incidence of bladder cancer rises, there is an increased need for medical interventions and management of the condition. Bladder cancer often requires surgical interventions, such as cystectomy (removal of the bladder) or other procedures. Catheters are commonly used post-surgery to help drain urine, manage urinary incontinence, and assist in the healing process. Some bladder cancer patients may require long-term catheterization, either intermittently or indwelling, to manage urinary issues. This creates a sustained demand for catheters.
The major players in the industry are actively seeking regulatory approval for intravenous (IV) catheters, a factor that contributes to the growth of the market. As a result, patients can benefit from the availability of advanced and improved catheters that significantly enhance their quality of life. Additionally, this regulatory approval process opens up opportunities for manufacturers to create innovative and new products to meet market demands. For instance, in March 2023, Shockwave Medical, Inc. received approval from the U.S. FDA for its Shockwave L6 Peripheral Intravascular Lithotripsy (IVL) Catheter. This catheter was designed to address the challenge of calcification in tumors within significant peripheral vessels, including femoral and iliac arteries, which are notoriously hard to treat. These arteries often experience calcification, causing more complications and reducing the success rates of endovascular surgeries. Consequently, the market is anticipated to witness growth in the coming years due to such initiatives.